{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:51Z","timestamp":1789506351410,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103018","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:46:46Z","timestamp":1788274006000},"page":"103018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-3836","authenticated-orcid":false,"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103018_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41586-025-09191-9","article-title":"Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions","volume":"8078","author":"Andersen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103018_bib2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.103018_bib3","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.cell.2025.05.019","article-title":"MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma","volume":"188","author":"Kenchappa","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib4","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103018_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.immuni.2025.04.017","article-title":"Complex neural-immune interactions shape glioma immunotherapy","volume":"58","author":"Song","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103018_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cell.2019.01.006","article-title":"Optimal-Transport Analysis of Single-Cell Gene Expression Identifies Developmental Trajectories in Reprogramming","volume":"176","author":"Schiebinger","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41580-021-00335-z","article-title":"Direct cell reprogramming: approaches, mechanisms and progress","volume":"22","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103018_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tcb.2023.07.013","article-title":"Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective","volume":"34","author":"Huyghe","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103018_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib10","doi-asserted-by":"crossref","DOI":"10.1242\/dev.203090","article-title":"Manipulating cell fate through reprogramming: approaches and applications","volume":"151","author":"Yagi","year":"2024","journal-title":"Development"},{"key":"10.1016\/j.xcrm.2026.103018_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuron.2020.07.026","article-title":"Transcriptional Reprogramming of Distinct Peripheral Sensory Neuron Subtypes after Axonal Injury","volume":"108","author":"Renthal","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2026.103018_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrm.2016.8","article-title":"A decade of transcription factor-mediated reprogramming to pluripotency","volume":"17","author":"Takahashi","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103018_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.stem.2015.06.003","article-title":"Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons","volume":"17","author":"Li","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib14","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","article-title":"In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming","volume":"167","author":"Ocampo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41556-023-01191-z","article-title":"H3K36 methylation maintains cell identity by regulating opposing lineage programmes","volume":"25","author":"Hoetker","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103018_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41586-022-05311-x","article-title":"Phenotypic plasticity and genetic control in colorectal cancer evolution","volume":"611","author":"Househam","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103018_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107994","article-title":"The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations","volume":"300","author":"Masciale","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.103018_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41422-018-0111-x","article-title":"Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors","volume":"29","author":"Cheng","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.103018_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-025-08915-1","article-title":"Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation","volume":"642","author":"Hosseini","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103018_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","article-title":"Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis","volume":"35","author":"Ishay-Ronen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103018_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103018_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau4292","article-title":"Direct reprogramming of fibroblasts into antigen-presenting dendritic cells","volume":"3","author":"Rosa","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.103018_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf4432","article-title":"Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT","volume":"6","author":"Zhang","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.103018_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.immuni.2016.11.006","article-title":"Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification","volume":"46","author":"Grajkowska","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103018_bib26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/2326-6066.CIR-23-0721","article-title":"Machine Learning\u2013Directed Conversion of Glioblastoma Cells to Dendritic Cell\u2013Like Antigen-Presenting Cells as Cancer Immunotherapy","volume":"12","author":"Liu","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.103018_bib27","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2007-04-083188","article-title":"Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity","volume":"110","author":"Dannull","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103018_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/neuonc\/nox170","article-title":"Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model","volume":"20","author":"Shibao","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103018_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103018_bib30","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103018_bib31","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","article-title":"Cancer vaccines: Building a bridge over troubled waters","volume":"185","author":"Sellars","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib32","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.stem.2021.09.002","article-title":"Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy","volume":"28","author":"Lentini","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103018_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.brainres.2015.10.012","article-title":"New approaches for direct conversion of patient fibroblasts into neural cells","volume":"1656","author":"Gopalakrishnan","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2026.103018_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.stemcr.2019.11.003","article-title":"Precision Health Resource of Control iPSC Lines for Versatile Multilineage Differentiation","volume":"13","author":"Hildebrandt","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103018_bib35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.116.305374","article-title":"Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications","volume":"116","author":"Sadahiro","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103018_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2026.103018_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16122211","article-title":"Dendritic Cells in Shaping Anti-Tumor T Cell Response","volume":"16","author":"Mazzoccoli","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.103018_bib38","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.adg8802","article-title":"Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells","volume":"380","author":"Rodr\u00edguez-Silvestre","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103018_bib39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: the promise and challenges of cancer immunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103018_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.smim.2013.02.002","article-title":"PD-1 coinhibitory signals: the link between pathogenesis and protection","volume":"25","author":"Kulpa","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2026.103018_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of Lipid Nanoparticles for RNA Delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.xcrm.2026.103018_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.103018_bib43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.103018_bib44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.molmed.2025.01.015","article-title":"Gene therapies for neurogenetic disorders","volume":"31","author":"Devinsky","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103018_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115190","article-title":"mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond","volume":"206","author":"Estap\u00e9 Senti","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.103018_bib46","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1021\/acsbiomaterials.9b00434","article-title":"PCSK9 Hapten Multicopy Displayed onto Carrier Protein Nanoparticle: An Antiatherosclerosis Vaccine","volume":"5","author":"You","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.xcrm.2026.103018_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/lifemedi\/lnac036","article-title":"NTLA-2001: opening a new era for gene therapy","volume":"1","author":"Cui","year":"2022","journal-title":"Life Med."},{"key":"10.1016\/j.xcrm.2026.103018_bib48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:14:12Z","timestamp":1789503252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004350"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103018","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103018"}}